Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 1,585-1,596 of 10,592
Drug study icon
RecruitingNCT07278505

Cannabidiol and Neuroimaging on Stress

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AnxietyDrugA study involving a medication or substance.From 18 Years to 25 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Anxiety
Drug study icon
RecruitingNCT04899687

Dextromethorphan in OCD and Related Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States
OCD, AnxietyDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Stanford University
Condition
OCD, Anxiety
Other study type icon
RecruitingNCT03100656

Food Aversion in people with Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Eating disordersOtherFrom 18 Years to 55 Years
Countries
United States, Canada
Sponsor
University of California, San Diego
Condition
Eating disorders
Drug study icon
RecruitingNCT06480383

ITI-1284 as an Adjunctive Treatment in people with Generalized Anxiety Disorder

This study exists to compare options and see whether the medication ITI-1284 offers something meaningfully different. Researchers are trying to understand whether the medication ITI-1284 can give earlier or clearer feedback during care.

In United States
AnxietyDrugOver 18 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Anxiety
Drug study icon
RecruitingNCT06701903

ITI-1284 as Monotherapy Treatment in people with Generalized Anxiety Disorder

This study exists to compare options and see whether the medication ITI-1284 offers something meaningfully different. Researchers are trying to understand whether the medication ITI-1284 can give earlier or clearer feedback during care.

In United States
AnxietyDrugOver 18 Years
Countries
United States, Bulgaria, Finland, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Anxiety
Drug study icon
RecruitingNCT06462586

Lumateperone in the Acute Treatment of people with Bipolar Mania

This observational study is following people with bipolarity, Manic to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity
Drug study icon
RecruitingNCT06462612

Lumateperone in the Treatment of people with Bipolar Mania

This observational study is following people with bipolarity, Manic to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Bulgaria, Romania, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity
Behavioral study icon
RecruitingNCT00018057

Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

This study is comparing Attention Bias Modification Training with Control for people with anxiety or depression. Participants receive Attention Bias Modification Training or Control and complete study visits and assessments.

In United States
Depression, AnxietyBehavioralFrom 8 Years to 65 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression, Anxiety
Drug study icon
RecruitingNCT07520292

NTX-2001 on Alcohol Consumption in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 60 Years
Countries
United States
Sponsor
Newleos Therapeutics, Inc.
Condition
Addiction
Drug study icon
RecruitingNCT06399263

Psilocybin for Anorexia in Young Adults

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Eating disordersDrugFrom 18 Years to 25 Years
Countries
United States
Sponsor
Marissa Raymond-Flesch, MD, MPH
Condition
Eating disorders
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.